
    
      A randomized, open-label, multiple-dose, two-arm, one-sequence Â· crossover study to evaluate
      the safety and pharmacokinetics after oral concurrent administration telmisartan/s-amlodipine
      and rosuvastatin in healthy volunteers.
    
  